Silencing CHD1L expression in HCC by the corresponding shRNA has a great therapeutic potential in HCC treatment, especially to increase the chemo-sensitivity combined with 5-FU chemotherapy [32]. Here, CHD1L is linked to hepatocellular carcinoma.